Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
In Phase 2 trials over 48 weeks, participants at the 12mg dose achieved an average of 24.2% body weight reduction, outpacing both Semaglutide (14.9%) and Tirzepatide (20.9%) in comparative data
This article provides clear, practical steps for selecting and adjusting a maintenance dose, recognizing warning signs, and developing a follow-up plan to prevent weight regain
This product is designed for those who value peak aesthetics and seek a flawless, glass-skin complexion
The following features would enhance the value of an obesity therapeutic, but would likely be assessed in follow-up trials or even post-approval: Additional efficacy in obesity-related co-morbidities
MK-677 was administered at 4 mg/kg via the stomach tube between 08:00 and 10:00 for 6 weeks
Other Ingredients: Proprietary Lipid Blend (sunflower oil and palm oil), hydroxypropyl methylcellulose (vegetable capsule)
US$ 20.00
US$ 20.48
US$ 28.21
US$ 21.84
US$ 25.13
US$ 26.43
US$ 22.87
US$ 25.88
US$ 23.28
US$ 26.02
US$ 24.25
US$ 29.32
